Skip to main content

01.08.2014 | Original Article

Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women

verfasst von: Giorgio Bedogni, Amalia Gastaldelli, Claudio Tiribelli, Fiorenza Agosti, Alessandra De Col, Rezene Fessehatsion, Alessandro Sartorio

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of type 2 diabetes mellitus (T2DM). Insulin resistance and beta-cell dysfunction are involved in the pathogenesis of T2DM. Insulin resistance is associated with NAFLD but little is known about beta-cell dysfunction and NAFLD.

Aim

We tested whether NAFLD severity is associated with insulin sensitivity and beta-cell function in morbidly obese women.

Subjects and methods

We studied 61 Caucasian women aged 18–60 years without T2DM and with a body mass index ranging from 35.3 to 48.8 kg/m2. The insulin sensitivity index (ISI) and the disposition index (DI) from oral glucose tolerance testing were used as measures of insulin sensitivity and beta-cell function, respectively. Fat was measured by dual-energy X-ray absorptiometry. Fatty liver was diagnosed by ultrasonography and ordinally coded as 0 = none, 1 = light, 2 = moderate, 3 = severe. Proportional-odds logistic regression was used to evaluate the association of NAFLD severity with logeISI and logeDI with and without correction for total and truncal fat.

Results

The odds of more severe vs. less severe NAFLD decreased for increasing logeISI [odds ratio (OR) 0.40, 95 % CI 0.19–0.84, p < 0.05] and logeDI (OR 0.80, 95 % CI 0.69–0.92, p < 0.01). Neither total nor truncal fat had any effect on these associations.

Conclusion

In morbidly obese women, NAFLD severity is inversely associated with insulin sensitivity and beta-cell function. The association of NAFLD severity with beta-cell dysfunction is stronger than that with insulin resistance.
Literatur
1.
Zurück zum Zitat Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285PubMedCrossRef Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274–285PubMedCrossRef
2.
Zurück zum Zitat Musso G, Gambino R, Cassader M et al (2011) Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43:617–649PubMedCrossRef Musso G, Gambino R, Cassader M et al (2011) Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 43:617–649PubMedCrossRef
3.
Zurück zum Zitat Lattuada G, Ragogna F, Perseghin G (2011) Why does NAFLD predict type 2 diabetes? Curr Diab Rep 11:167–172PubMedCrossRef Lattuada G, Ragogna F, Perseghin G (2011) Why does NAFLD predict type 2 diabetes? Curr Diab Rep 11:167–172PubMedCrossRef
4.
Zurück zum Zitat DeFronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795PubMedCentralPubMedCrossRef DeFronzo RA (2009) Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Gastaldelli A, Ferrannini E, Miyazaki Y et al (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31–39PubMedCrossRef Gastaldelli A, Ferrannini E, Miyazaki Y et al (2004) Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia 47:31–39PubMedCrossRef
6.
Zurück zum Zitat DeFronzo RA, Tripathy D, Schwenke DC et al (2013) Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes 62:3920–3926PubMedCrossRef DeFronzo RA, Tripathy D, Schwenke DC et al (2013) Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes 62:3920–3926PubMedCrossRef
7.
Zurück zum Zitat Gaggini M, Morelli M, Buzzigoli E et al (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5:1544–1560PubMedCentralPubMedCrossRef Gaggini M, Morelli M, Buzzigoli E et al (2013) Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5:1544–1560PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Bedogni G, Bellentani S, Miglioli L et al (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33PubMedCentralPubMedCrossRef Bedogni G, Bellentani S, Miglioli L et al (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Gastaldelli A, Kozakova M, Højlund K et al (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537–1544PubMedCrossRef Gastaldelli A, Kozakova M, Højlund K et al (2009) Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 49:1537–1544PubMedCrossRef
10.
Zurück zum Zitat Rijkelijkhuizen JM, Doesburg T, Girman CJ et al (2009) Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Metabolism 58:196–203PubMedCrossRef Rijkelijkhuizen JM, Doesburg T, Girman CJ et al (2009) Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Metabolism 58:196–203PubMedCrossRef
11.
Zurück zum Zitat Bedogni G, Gastaldelli A, Agosti F et al (2012) Impact of percent body fat on oral glucose tolerance testing: a cross-sectional study in 1512 obese children. J Endocrinol Invest 35:893–896PubMed Bedogni G, Gastaldelli A, Agosti F et al (2012) Impact of percent body fat on oral glucose tolerance testing: a cross-sectional study in 1512 obese children. J Endocrinol Invest 35:893–896PubMed
12.
Zurück zum Zitat Park SH, Kim BI, Kim SH et al (2007) Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. J Am Coll Nutr 26:321–326PubMedCrossRef Park SH, Kim BI, Kim SH et al (2007) Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. J Am Coll Nutr 26:321–326PubMedCrossRef
13.
Zurück zum Zitat Subramanian V, Johnston RD, Kaye P et al (2013) Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 37:455–463PubMedCrossRef Subramanian V, Johnston RD, Kaye P et al (2013) Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 37:455–463PubMedCrossRef
14.
Zurück zum Zitat Bedogni G, Grugni G, Nobili V et al (2014) Is non-alcoholic fatty liver disease less frequent among women with Prader-Willi syndrome? Obes Facts 7:71–76PubMedCrossRef Bedogni G, Grugni G, Nobili V et al (2014) Is non-alcoholic fatty liver disease less frequent among women with Prader-Willi syndrome? Obes Facts 7:71–76PubMedCrossRef
15.
Zurück zum Zitat Bedogni G, Agosti F, De Col A et al (2013) Comparison of dual-energy X-ray absorptiometry, air displacement plethysmography and bioelectrical impedance analysis for the assessment of body composition in morbidly obese women. Eur J Clin Nutr 67:1129–1132PubMedCrossRef Bedogni G, Agosti F, De Col A et al (2013) Comparison of dual-energy X-ray absorptiometry, air displacement plethysmography and bioelectrical impedance analysis for the assessment of body composition in morbidly obese women. Eur J Clin Nutr 67:1129–1132PubMedCrossRef
16.
Zurück zum Zitat Lohman TG, Roche AF, Martorell R (1988) Anthropometric standardization reference manual. Human Kinetics Books, Champaign Lohman TG, Roche AF, Martorell R (1988) Anthropometric standardization reference manual. Human Kinetics Books, Champaign
17.
Zurück zum Zitat WHO (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization, Geneva WHO (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization, Geneva
18.
Zurück zum Zitat World Health Organization (WHO) (2006) Definition and diagnosis of diabetes. WHO, Geneva World Health Organization (WHO) (2006) Definition and diagnosis of diabetes. WHO, Geneva
19.
Zurück zum Zitat Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470PubMedCrossRef
20.
Zurück zum Zitat Bedogni G, Gastaldelli A, Manco M et al (2012) Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutr Metab Cardiovasc Dis 22:120–126PubMedCrossRef Bedogni G, Gastaldelli A, Manco M et al (2012) Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutr Metab Cardiovasc Dis 22:120–126PubMedCrossRef
21.
Zurück zum Zitat Bedogni G, Kahn HS, Bellentani S et al (2010) A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 10:98PubMedCentralPubMedCrossRef Bedogni G, Kahn HS, Bellentani S et al (2010) A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol 10:98PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Hernaez R, Lazo M, Bonekamp S et al (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082–1090PubMedCrossRef Hernaez R, Lazo M, Bonekamp S et al (2011) Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 54:1082–1090PubMedCrossRef
23.
Zurück zum Zitat Ratziu V, Bellentani S, Cortez-Pinto H et al (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53:372–384PubMedCrossRef Ratziu V, Bellentani S, Cortez-Pinto H et al (2010) A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 53:372–384PubMedCrossRef
24.
Zurück zum Zitat Agresti A (2010) Analysis of ordinal categorical data. Wiley, HobokenCrossRef Agresti A (2010) Analysis of ordinal categorical data. Wiley, HobokenCrossRef
25.
Zurück zum Zitat Hosmer DW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley, HobokenCrossRef Hosmer DW, Lemeshow S, Sturdivant RX (2013) Applied logistic regression. Wiley, HobokenCrossRef
26.
Zurück zum Zitat Belsey DA, Kuh E, Welsch RE (1980) Regression diagnostics identifying influential data and sources of collinearity. Wiley, New YorkCrossRef Belsey DA, Kuh E, Welsch RE (1980) Regression diagnostics identifying influential data and sources of collinearity. Wiley, New YorkCrossRef
27.
Zurück zum Zitat Royston P, Sauerbrei W (2008) Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Wiley, ChichesterCrossRef Royston P, Sauerbrei W (2008) Multivariable model-building: a pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables. Wiley, ChichesterCrossRef
28.
Zurück zum Zitat Long JS, Freese J (2006) Regression models for categorical dependent variables using Stata. StataCorp, College Station Long JS, Freese J (2006) Regression models for categorical dependent variables using Stata. StataCorp, College Station
29.
Zurück zum Zitat Nobili V, Alisi A, DellaCorte C et al (2013) Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children. Nutr Metab Cardiovasc Dis 23:1066–1070PubMedCrossRef Nobili V, Alisi A, DellaCorte C et al (2013) Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children. Nutr Metab Cardiovasc Dis 23:1066–1070PubMedCrossRef
Metadaten
Titel
Relationship between glucose metabolism and non-alcoholic fatty liver disease severity in morbidly obese women
verfasst von
Giorgio Bedogni
Amalia Gastaldelli
Claudio Tiribelli
Fiorenza Agosti
Alessandra De Col
Rezene Fessehatsion
Alessandro Sartorio
Publikationsdatum
01.08.2014
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 8/2014
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-014-0101-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.